Back to Browse Journals » Vascular Health and Risk Management » Volume 9

Current and future initiatives for vascular health management in clinical practice

Authors Cameron JD, Asmar R, Struijker-Boudier H, Shirai K, Sirenko Y, Kotovskaya Y, Topouchian J

Published Date May 2013 Volume 2013:9 Pages 255—264

DOI http://dx.doi.org/10.2147/VHRM.S42947

Received 18 January 2013, Accepted 30 November 1999, Published 28 May 2013

James D Cameron,1 Roland Asmar,2 Harry Struijker-Boudier,3 Kohji Shirai,4 Yuriy Sirenko,5 Yulia Kotovskaya,6 Jirar Topouchian7

1Monash Cardiovascular Research Centre, Clayton, Melbourne, Victoria, Australia; 2Roland Asmar, Foundation Medical Research Institutes, Paris, France; 3Department of Pharmacology, Maastricht University, Maastricht, The Netherlands; 4Department of Vascular Function, Sakura Hospital, Toho University, Tokyo, Japan; 5Institute of Cardiology, Kiev, Ukraine; 6ESH Hypertension Excellence Center of Peoples Friendship University of Russia, Moscow, Russia; 7Department of Diagnosis and Therapeutics, Hôtel-Dieu University Hospital, Paris, France

Abstract: Central arterial structure and function comprise a primary determinant of vascular health, and are integral to the important concept of ventriculo-vascular coupling or interaction. Central aortic stiffening is a major influence on central blood pressure, and directly relates to coronary perfusion. The joint session of the International Society of Vascular Health (Eastern Region) and the Ukrainian Congress of Cardiology was held in Kiev, Ukraine, on September 23, 2011; it provided an expert forum to discuss arterial evaluations, clinical applications, and progress toward translating arterial protection into cardiovascular benefits. The conclusions of the expert panel were:
1. Aortic stiffness is not presently a treatment target but may be useful for substratifying cardiovascular risk in individuals in order to better target the intensity of conventional therapy, and it may be useful in assessing response to treatment.
2. Crosstalk between macro- and microcirculation in hypertension has important implications for pharmacological treatment. An antihypertensive regimen should abolish the vicious cycle between the increased resistance in the microcirculation and the increased stiffness of the larger arteries. Such treatment should be based on drugs with multiple actions on the vascular tree, or on drug combinations that target the various segments of the arterial system.
3. Several blood pressure-independent mechanisms of large artery stiffness exist. Future considerations for clinical understanding of large artery stiffness should involve new drugs and new evaluation methods – with a focus on vascular health, for the initiation of cardiovascular prevention, for newly designed studies for treatment evaluation, and for new studies of drug combinations.
4. Arterial stiffening is a sign of cardiovascular aging and is a major factor affecting the biomechanics of large arteries. Arterial stiffness is an attractive therapeutic target in terms of vascular aging. Healthy lifestyle, physical exercise, and smoking cessation are the most effective ways of preventing and treating early vascular aging. Long-term effects of cardiovascular drugs on arterial stiffness need to be further investigated.
5. The emerging clinical data on the cardio ankle vascular index (CAVI) technique of arterial health assessment is presented, showing that the CAVI is elevated in aging, coronary artery diseases, chronic kidney disease, hypertension, diabetes mellitus, smoking, and stress. The CAVI decreased with the administration of statins, angiotensin II receptor blocking agents, and calcium channel blockers. The CAVI is suggested as an important predictor of cardiovascular diseases.
Future development of a clinical understanding of large artery stiffness is important and should include consideration of new drugs and new evaluation methods, with a focus on vascular health aimed at cardiovascular prevention.

Keywords: arterial stiffness, cardiovascular protection, hypertension, arterial hemodynamic evaluation

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Management of dyslipidemia and hyperglycemia with a fixed-dose combination of sitagliptin and simvastatin

Steinberg H, Anderson MS, Musliner T, Hanson ME, Engel SS

Vascular Health and Risk Management 2013, 9:273-282

Published Date: 29 May 2013

Phenomenological perspectives on self-care in aging

Söderhamn O

Clinical Interventions in Aging 2013, 8:605-608

Published Date: 29 May 2013

Predictive value of the fragmented QRS complex in 6-month mortality and morbidity following acute coronary syndrome

Akbarzadeh F, Pourafkari L, Ghaffari S, Hashemi M, Sadeghi-Bazargani H

International Journal of General Medicine 2013, 6:399-404

Published Date: 28 May 2013

Results of case-control studies support the association between contact lens use and Acanthamoeba keratitis

Pacella E, La Torre G, De Giusti M, Brillante C, Lombardi AM, Smaldone G, Lenzi T, Pacella F

Clinical Ophthalmology 2013, 7:991-994

Published Date: 28 May 2013

 Telangiectatic osteosarcoma: a review of literature

Liu J, Liu S, Wang J, Zhu W, Hua Y, Sun W, Cai Z

OncoTargets and Therapy 2013, 6:593-602

Published Date: 28 May 2013

Screening for subclinical atherosclerosis by noninvasive methods in asymptomatic patients with risk factors

Castellon X, Bogdanova V

Clinical Interventions in Aging 2013, 8:573-580

Published Date: 28 May 2013

Newer agents in antiplatelet therapy: a review

Yeung J, Holinstat M

Journal of Blood Medicine 2012, 3:33-42

Published Date: 25 June 2012